Mirugen – Unlocking the Power of Retina Regeneration
Mirugen – Unlocking the Power of Retina Regeneration
Search
Search results
Frequently asked questions
These frequently asked questions should provide a response for most of the queries you might raise.
Medical Advisory Board
Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.
About inherited sight loss
Many inherited sight loss conditions occur when cells in the retina, which is the light-sensitive region at the back of the eye, deteriorate in an unpredictable way. These conditions are often referred to as inherited retinal dystrophies.
Corporate partnerships
Our partnerships are mutually beneficial. For Retina UK this means we can fund more research and offer support on a local level, while our partners can achieve corporate social responsibility objectives whilst making a tangible impact.
50th Anniversary Raffle 2025
During our 50th Anniversary year, get involved in our annual Raffle! You could win 5 incredible prizes and support Retina UK at the same time.
Webinar: Dr Salwah Rehman, Clinical trials process
A general overview of the clinical trials process and practicalities, including issues to consider if you are given the opportunity to take part.
Oxfordshire information event (online)
Our Keynote speaker will be Mr Kanmin Xue. Mr Xue is a Consultant Vitreo-retinal Surgeon at the John Radcliffe Hospital and Wellcome Trust clinician scientist fellow at the University of Oxford where he leads the Retinal Disease and Repair Group.
CRISPR Gene Editing Leads to Improvements
CRISPR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows.
Webinar: Ask the Expert: Dr Roly Megaw
This time we are joined by Roly Megaw, Clinical Lecturer and Honorary Consultant Ophthalmologist at University of Edinburgh and NHS Lothian